Extracorporeal Photochemotherapy (ECP) is a widely applied anti-cancer immunotherapy
for patients with cutaneous T cell lymphoma (CTCL). By using apoptotic malignant cells as a …

Extracorporeal photochemotherapy (ECP) is a cancer immunotherapy for cutaneous T-cell
lymphoma (CTCL) operative in more than 350 centers worldwide. Although its efficacy and …

Extracorporeal photochemotherapy (ECP) is a widely used cancer immunotherapy for
cutaneous T cell lymphoma (CTCL), operative in over 350 university centers worldwide …

Extracorporeal photopheresis (ECP) emerged as a systemic first-line therapy in leukemic
cutaneous T-cell lymphoma (L-CTCL) and is now being implemented in a variety of T-cell …

Extracorporeal photochemotherapy (ECP), or photopheresis, was originally introduced for
the management of patients with cutaneous T cell lymphoma (CTCL). Today, ECP remains …

Extracorporeal photochemotherapy (ECP), or photopheresis, is a widely used treatment for
cutaneous T cell lymphoma (CTCL) and other T cell‐mediated disorders, having been …

We are now aware that extracorporeal photopheresis (ECP)–in which a patient's leukocytes
are isolated, passed through an ultrathin clear plastic plate, and exposed to 8 …

Extracorporeal photochemotherapy (ECP) is a widely used immunotherapy for cutaneous T
cell lymphoma (CTCL). It involves four sequential steps: conversion of blood monocytes into …

Background Extracorporeal photopheresis (ECP) has emerged as a systemic first-line
immunomodulatory therapy in leukaemic cutaneous T-cell lymphoma (L-CTCL) and is now …

Background Extracorporeal photopheresis (ECP) has emerged as a systemic first-line
immunomodulatory therapy in leukaemic cutaneous T-cell lymphoma (L-CTCL) and now …